Clinical Trial: A Study With CIT-013 in HS Patients

U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06993233) titled 'A Study With CIT-013 in HS Patients' on May 19.

Brief Summary: The goal of this clinical trial is to learn if CIT-013 works to treat Hidradenitis Suppurativa in adults. It will also learn about the safety of CIT-013. The main questions it aims to answer are:

Does CIT-013 lower the disease activity of HS patients? What medical problems do participants have when receiving CIT-013? Researchers will compare CIT-013 to a placebo (a look-alike substance that contains no drug) to see if CIT-013 works to treat the symptoms of HS.

Participants will:

Take receive 50 or 100 mg CIT-013 or placebo every other week for 12 weeks Visit the clinic...